Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Giacomini Lab, |
RCV002286661 | SCV002576678 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV002286661 | SCV003780471 | uncertain significance | Renal carnitine transport defect | 2022-03-31 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 267 of the SLC22A5 protein (p.Gly267Ala). This variant is present in population databases (rs775430253, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV004793760 | SCV005411865 | uncertain significance | not provided | 2024-05-16 | criteria provided, single submitter | clinical testing |